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Protein rekombinan seperti vaksin, antibodi, hormon, dan obat-obatan, semakin 
dibutuhkan oleh ternak dan manusia. Hambatan utama untuk menghasilkan 
protein rekombinan pada Escherichia coli sebagai inang yang digunakan paling 
luas adalah degradasi oleh enzim proteolitik. Hal ini disebabkan karena E. coli 
memiliki sejumlah enzim proteolitik yang tersebar di dalam sitoplasmanya. 
Untuk itu, lebih dari 90% degradasi protein terjadi di dalam sitoplasmanya. 
Pada penelitian ini, peneliti telah menghasilkan mutant E. coli BW25113 yang 
tidak memiliki gen penyandi enzim protease dengan menggunakan kombinasi 
metode pengerusakan kromosom dan metode transduksi phage P1. Pembuatan 
mutan tersebut dimulai dengan pengerusakan gen penyandi enzim protease 
pada kromosom bakteri dengan produk PCR yang memiliki bagian yang 
homolog dengan gen target. Mutan-mutan yang dihasilkan kemudian 
digunakan untuk menghasilkan mutan ganda dengan metode Transduksi phage 
P1.  Analisis fenotif dan genotif menunjukkan bahwa kombinasi kedua metode 
tersebut sangat efektif untuk membuat lebih dari satu mutasi pada E. coli. 
Untuk itu, mutan E. coli yang telah diperoleh akan sangat bermanfaat untuk 
menghasilkan aneka protein rekombinan untuk ternak dan manusia.  
 
Recombinant proteins, such as vaccines, antibodies, hormone, or drugs, are 
increasingly needed for cattle and human. The major constrain in the 
recombinant proteins production using Escherichia coli, the most widely used 
host strains, is their degradation by proteolytic enzymes. It is most likely that 
the E. coli possesses a number of proteolytic enzymes distributed in its 
cytoplasm. Therefore, more than 90% of the degradation process occurs in the 
cytoplasm. In this study, we constructed protease-deficient mutants in E. coli 
BW25113 using combination of chromosomal disruption and P1 phage 
transduction methods. The mutant construction began with the disruption of 
chromosomal gene encoding protease in E. coli by one-step disruption method in 
which  PCR  products  provide  the  homology  regions  to  the  targeted  gene(s). 
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 These mutants were used to construct double mutants using P1 phage 
transduction. Phenotypic and genetic analysis showed that the combination of 
these methods were effective to construct more than one gene disruption in E. 
coli. Therefore, the obtained E. coli mutants would be absolutely useful for the 
generation of wide varieties of recombinant proteins for cattle and human. 
 
 
In recent years, recombinant protein 
technology has become an important 
discipline spanning from scientific research to 
the pharmaceutical industry. It is considered 
so since recombinant proteins, such as 
vaccines, antibodies, hormone, or drugs, are 
increasingly needed for cattle and human 
health. The use of cowpox firstly as smallpox 
vaccine by Edward Jenner, followed by 
attenuated or killed virulent micro-organisms 
and recombinant proteins to fight disease has 
proven spectacularly successful. Appropriate 
administration of attenuated or killed Bacillus 
anthracis is very effective to prevent anthrax 
disease in farm animals. In addition, passive 
antibody therapies and immune sera could be 
used for treatment of certain infections in 
animal. 
 One of the challenges emerged in the 
biotechnology revolution to meet animals and 
humans demand is the development of 
techniques for the economical production of 
therapeutics recombinant proteins. Plant 
production system has been developed for 
the proteins production (Kersten et al., 2003; 
Valdes et al., 2003). Plants are potential 
“biofarming factories” because they are 
capable of producing unlimited number and 
amount of recombinant proteins safely and 
inexpensively. However, some of the current 
hurdles include a long growth time, regula-
tory elements uncertainties, and questions 
about the suitability of plant glycans for 
human therapeutics.  
 Among the most well documented 
and established systems used in various 
scales of recombinant protein production are 
the enterobacterium Escherichia coli. It is the 
most ubiquitous source of recombinant 
protein as it is simple, cheap, and its 
technology is mature (Kristensen et al., 2005; 
Lombardi et al., 2005). Recombinant protein 
from bacteria, archaeabacteria, and 
eukaryotes are in many cases efficiently 
expressed and accumulated in E. coli 
(Kristensen et al., 2005). In addition, high 
production levels of recombinant proteins are 
usually attainable when E. coli is used as the 
host cells. 
 A major bottleneck in the proteins 
production using E. coli, is their degradation 
by proteolytic enzimes. It is due to the 
capacility of E. coli to produce a number of 
proteolytic enzymes distributed in its 
periplasm and cytoplasm. Previous studies 
demonstrated that endogenous proteases 
such as Lon, ClpP, DegP, and OmpT 
participated in rapid degradation of proteins 
in vivo (Vasilyeva et al., 2000; Weichard et al., 
2002; Jones, 2002; Ignatova et al., 2003; Okuno 
et al., 2002). Therefore, more than 90% of the 
degradation occure in the cytoplasm. 
 One way to enhance the yield of 
recombinant proteins of interest in E. coli as a 
host is genetic manipulation. Ignatova et al., 
(2003) reported that the production of mature 
active penicillin amidase increased up to 10-
fold when the protease-deficient strain E. coli 
BL21 (DE3) was used as the host. Therefore, 
the use of protease-deficient strains as the 
host is a successful strategy to achieve higher 
productivity of a proteolysis-susceptible 
target protein.  
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Genetic manipulation in bacteria 
genome can be achieved by a variety of 
techniques including error-prone PCR, DNA 
shuffling, saturation mutagenesis, and family 
shuffling (Fuji et al., 2004). Error-prone PCR 
introduces random mutations during PCR by 
reducing the fidelity of DNA polymerase. The 
fidelity of DNA polymerase can be reduced 
by adding manganese ions or by biasing the 
dNTP concentration. The combination of 
error-prone PCR and saturation mutagenesis 
constitutes an efficient way to explore the 
protein mutation properties. However, the 
creation of mutants by the above methods has 
been limited partly by point mutations that 
can introduce only a limited range of amino 
acid substitutions. This limitation narrows the 
sequence space of mutant proteins that can be 
created.  
 In this work, we generated several 
single protease-deficient mutants of E. coli 
using one-step chromosomal disruption 
method (Datsenko et al., 2000). Parallel efforts 
were performed for the construction of 
double protease-deficient mutants using P1 
Phage transduction method (Miller, 1972). 
The combination of one-step chromosomal 
disruption and P1 phage transduction 
methods was effective to construct more than 
one gene disruption in E. coli and would be 
widely useful for generating effective host of 
recombinant protein expression in other 
bacteria. 
 
MATERIALS AND METHODS 
 
Materials 
 Escherichia coli strains, plasmids, and 
phage used in this study are listed in Table 1. 
Luria-Bertani medium containing 1% of 
tryptone, 0.5% of yeast extract, and 1% of 
NaCl were used for cultivation. Super 
Optimal Broth (SOB) medium consisted of 2% 
tryptone, 0.5% yeast extract, 10 mM NaCl, 
and 2.5% mM KCl. SOC medium containing 
SOB medium plus 10 mM MgCl2, 10 mM 
MgSO2, and 20 mM Glucose. The solid 
medium containing 1.5% agar or 0.5% agar 
for soft-agar overlays. When required, the 
solid or liquid media were supplemented 
with antibiotics at the following concentra-
tions i.e. 50 g/ml kanamycin; 10 g/ml 
chloramphenicol; and 50 g/ml ampicilin. 
 
Methods 
Construction of Mutant Strains 
The one-step chromosomal disruption 
method and P1 phage transduction method 
were prepared as previously described by 
Datsenko et al., (2000) and Miller, (1972) 
respectivelly. PCR products were generated 
using template plasmids (pKD3, pKD4, and 
pKD13) using primer with 60-nt extentions 
(Table 2). PCR mixture consisted of 10x Ex taq 
buffer, 0.2mM dNTP, 0.5 M each primer, 0.01 
g/ l of template plasmid, and Ex Taq DNA 
polymerase. The PCR program consisted of 
an initial step at 94oC for 5 min, followed by 
30 cycle of 10 s at 94oC, 30 s at 55oC, and 1.5 
min at 72oC, followed by the final extension 
step of 7 min at 72oC.  
 
Electroporation 
Electroporation-competent cells 
(1010CFU/ml) were thawed quickly at room 
temperature and placed on ice. Disposable 
0.1-cm electroporation cuvettes (Bio-Rad) 
were placed in an ice for 10 min prior to 
electroporation. PCR products (1-3 µl) were 
mixed with 50 l of the competent cells. The 
mixture was pipetted into the precooled 
cuvettes (which were dried throughly) and 
electroporated at 20 kV and resistance of 200-
ohm. Immediately after electroporation, 1 ml 
of SOC medium was added to the cuvette. 
The cells were transferred to a 15 ml 
polypropylene tube and allowed to recover 
for 1 h at 30oC with shaking at 200 rpm before 
plating on selective media containing 
chloramphenicol and kanamycin.  
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PCR Verification 
 Phenotypic selection using selective 
media and PCR analysis were used to verify 
strain construction and recombinant forma-
tion. Primers (20-mers) (Table 2) were used to 
verify kanamycin or chlorampehnicol-
encoding gene replacement in protease-
encoding gene site. PCR mixture contained 
10x Ex Taq buffer, 0.2mM dNTP, 0.5 M each 
primer, 2.5 l of mutant colony dilution, and 
Ex Taq DNA polymerase. The mixture was 
incubated at 95oC for 5 min, followed by 30 
cycles of 30 s at 94oC, 30 s at 50oC, 2 min at 
72oC and a final extension step of 7 min at 
72oC. PCR products were run on 1% agarose 
gel along with a /Eco T141 marker. 
 
Elimination of Antibiotic Resistance Gene 
 Antibiotic resistance mutants were 
transformed with pCP20. Since the plasmid is 
an ampicilin plus chloramphenicol resistance 
plasmid, the results of transformation can be 
selected using selective media containing the 
antibiotic. Heat shock (43oC) for inducing FLP 
synthesis was performed for antibiotic 
resistance gene elimination. 
 
Table 1. Bacterial strains, plasmids and phage used in the experiment 
Strain or phage Chromosomal Markers/Description Source or reference 
E. coli BW25113 
(araD-araB)567, lacZ4787(::rrnB-3), lacIp-
4000(lacIQ), -, rph-1, (rhaD-rhaB)568, hsdR514 
Datsenko et al., 2000 
Plasmid 
pKD3, pKD4 pKD13 Template for PCR product Datsenko et al., 2000 
pKD46 The Red helper plasmid Datsenko et al. 2000 
pCP20 FLP recombinase Datsenko et al. 2000 
Phage 
P1 phage  Laboratory stock 
 
 
Table 2. List of primers used to verily kanamycein or chloramphonial encording gene 
replacement in protease encoding gene site 
Primers Sequence (5’        3’) 
degP-H1 
degP-H2 
DegP-L 
DegP-R 
Lon-H1 
Lon-H2 
Lon-L 
Lon-R 
ompT-H1 
ompT-H2 
OmpT-L 
OmpT-R 
clpP-H1 
clpP-H2 
ClpP-L 
ClpP-R 
acagcaattttgcgttatctgttaatcgagactggaatacgtgtaggc tggagctgcttc 
ggagaaccccttcccgttttcaggaaggggttgagggagac ata tgaatatcctcctta 
tatgaccgacctctatgcgt 
cctgtgaaagtaccagcaat 
atctgattacctggcggaaattaaactaagagagagctctgtga ggctggagctgcttc 
tgccagccctgtttttattagtgcattttgcgcgaggtcaattcc ggggatccgtcgacc 
cggtaattgatggtcaaagc 
cacgctctttaacggcaaa 
cggggcgattttcacctcggggaaattttagttggcgttcgtgta ggctggagctgcttc 
tacatattcaatcattaaaacgattgaatggagaacttttcatat gaatatcctccttagt 
cccagaaatgtggctataac 
cagcgacaaaaagtgatgtg 
atgtcatacagcggcgaacgagataactttgcaccccataattc cggggatccgtcgacc 
gatgggtcagaatcgaatcgaccagaccgtattccaccgcgtgt aggctggagctgcttc 
tcaacgagctgatgaaccag 
tatacacggatggaccggca 
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RESULTS  
 
 PCR products, which consist of 
antibiotic resistance gene with homologous 
regions, were generated by PCR from 
plasmids template  (pKD3, pKD4 and pKD13) 
using primers with 60-nt homologous 
extensions to the target. Each plasmid 
contains different antibiotic resistance genes 
that are flanked by directly repeated FRT site. 
pKD3 plasmid contain chloramphenicol  
resistance gene, pKD4 and pKD13 contain 
kanamycin resistance gene. The PCR 
products were purified, and digested with 
Dpn I. Transformation of the PCR products 
which contain a homologous region were 
then performed into E. coli BW25113 using 
electroporation method. After plating on 
selective media and incubating at 30oC 
overnihgt, the growing colonies were then 
used as template for PCR confirmation. 
 The generated single mutants were 
Lon-deficient mutant (  lon), ClpP-deficient 
mutant (  clpP), DegP-deficient mutant 
( degP), and OmpT-deficient mutant ( ompT). 
Electrophoresis result of PCR amplification of 
ClpP-deficient mutant (  clpP::Kmr) were 
shown in Figure 1 A. The band size of ClpP 
protease-deficient mutant (ΔclpP::Kmr) was 
higher than that of wild type (W1-W2) 
because of antibiotic resistance gene insertion 
between the homologous regions. 
 All of the single mutant that were still 
containing antibiotic resistance gene were 
subsequently used as donor cells for double 
mutant construction by means of P1 phage 
transduction. Receptor cells were prepared 
from these mutants following isolation of the 
antibiotic resistance gene. FRT sites placed in 
the same chromosome will lead to a deletion 
or inversion of the antibiotic resistance 
segment by FLP recombinase produced by 
the strain with an easy curable FLP-
expressing plasmid (pCP20) (Cherephanov et 
al., 1995). After excision of the antibiotic-
resistance determinant, as shown in 
electrophoresis results of  clpP (Figure 1A), 
the band size of  the mutant was lower than 
that of wild type.  
 Double-protease deficient mutant 
produced in this study were DegP + OmpT-
deficient mutant ( degP-ompT), DegP + Lon-
deficient mutant ( degP-lon), Lon + OmpT-
deficient mutant ( lon-ompT), and 
OmpT+ClpP-deficient mutant ( ompT-clpP). 
We also tried to construct triple mutant, but 
no colony was obtained. 
 Electrophoresis result of PCR 
amplification of OmpT and ClpP-deficient 
mutant were shown in Fig. 1 B. Replacement 
of protease gene by PCR products (antibiotic 
resistance segment) was increased the band 
size of these mutants (ΔompTclpP::Kmr) 
comparing to wild type. As occurred in single 
mutant,  the band size become lower than 
wild type after elimination of the antibiotic 
resistance cassette (ΔompTclpP).  
 To verify the effect of protease gene 
deletion on E. coli growth, some mutants and 
control (wild type) were grown in LB 
medium at 37 oC. Figure 2 shows that E. coli 
protease-deficient mutants were grown 
slowly than did the wild type (control). Each 
of single mutants has the same tendency to 
grow faster than double mutant, but was 
slower than the wild-type.  
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   A           B 
Fig. 1. Electrophoresis results of PCR confirmation of E. coli BW25113 protease-deficient mutants. A = single mutants 
(ΔclpP::Km = ClpP-deficient mutants containing kanamycin-encoding gene; ΔclpP = ClpP-deficient mutants without 
kanamycin-encoding gene; W1, W2, W = wild type, 1-4 = single mutants). B = double mutants (ΔompTclpP::Km = OmpT and 
ClpP-deficient mutant containing kanamycin-encoding gene; ΔompTclpP = OmpT and ClpP-deficient mutant without 
kanamycin-encoding gene; WT = wild type, 1-6 = double mutants). M = λ DNA marker. 
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Fig. 2. Time course of E. coli mutant growth Cells were grown at 37 oC. 1 = 
wild type/control, 2 = ompT, 3 = clpP, 4 = degP, 5 = clpP-ompT, 6 = lon, 7 = 
degP-lon, 8 = lon-ompT, 9 = degP-ompT. 
 
 
 
1 
2 
 3 
4 
5 
6 
7 
8 
9 
REKAYASA BAKTERI UNTUK TERNAK DAN MANUSIA: PEMBUATAN MUTAN ESCHERICHIA COLI 
PENGHASIL PROTEIN REKOMBINAN 
110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Heat Shock 
 
  
 
Fig. 3. A schematic showing simple steps of gene disruption strategy for mutant construction. 1 = PCR products 
were generated from plasmid (pKD3, pKD4 and pKD13) using primer with 60-nt extentions, 2 = Electroporation of 
PCR products into E. coli Red system for gene target replacement, 3 = electroporation of FLP-expressing plasmid 
(pCP20) into E. coli mutants for antibiotic resistance gene elimination, 4 = elimination of antibiotic resistance gene 
using heat-schock method. H1 and H2 refer to the homology regions, P1 and P2 refer to priming site. FRT = FLP 
recognition target. 
 
 
DISCUSSION 
 
 Since E. coli posseses a number of 
proteolytic enzyme, many recombinant 
proteins are rapidly degraded when 
expressed in the bacteria. Lon is the primary 
protease degrading abnormally folded 
proteins in E. coli. Outer membrane protease, 
OmpT, can cleave many cytoplasmic protein 
after lysis cells. In the periplasm, DegP is 
protease which has a serine active site. In 
addition, ClpP can associate with ATPase 
subunit to form protease (Gottesman, 1996; 
Hengge and Bukau, 2003). 
 The procedure for the construction of 
protease-deficient mutants using one-step 
chromosomal disruption method are shown 
diagrammatically in Figure 3 The basic 
principle of the chromosomal disruption 
method is to replace a target gene with a 
selectable antibiotic resistance gene and 
homologous regions. Linear DNA containing 
antibiotic resistance gene flanked by 
homologous regions of bacterial chromosome 
is then transformed or electroporated into 
recombination-proficient E. coli BW25113 
strain. Recombination between both ends of 
the linear DNA fragment and the bacterial 
 E. coli Red system 
target gene      
                    
FRT FRT 
 PCR 
PCR Product 
Antibiotic gene 
 
Electroporation 
 
H1 
P1 
antibiotic gene 
FRT FRT 
 
Electroporation 
 
 
FRT 
pCP20 
antibiotic resistence gene 
Plasmid (pKD3, 
pKD4, pKD13) 
H2 
P2 
1 
2 
3 
4 
Mutan
t 
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chromosome results in gene replacement. The 
recombinations can be easily selected by the 
presence of the antibiotic resistance marker. 
 The antibiotic resistance gene was 
generated by PCR from plasmids template  
(pKD3, pKD4 and pKD13) using primers with 
60-nt homologous extensions to the target. 
Each plasmid contains different antibiotic 
resistance genes that are flanked by directly 
repeated FRT site and homologous regions. 
pKD3 plasmid contain chloramphenicol  
resistance gene, pKD4 and pKD13 contain 
kanamycin resistance gene. The homologous 
regions were provided by primers with 60-
nucleotides homologous extensions. 
 Digestion of PCR products using Dpn 
I was done to eliminate methylated 
(unamplified) template DNA. The linear 
DNA (PCR product) was then electroporated 
into transformants (E. coli BW25113) carrying 
the Red helper plasmid. In one-step 
chromosomal disruption method, target gene 
replacement with antibiotic resistance gene 
was conducted based on the Red system. 
Transformants, which carrying pKD46, have 
three genes (exo,  and ) that facilitate and 
are necessary for recombination (Datsenko et 
al., 2000). The exo gene encodes the Red  
protein, a 5’ to 3’ exonuclease that 
processively degrades the 5’-ended strand of 
a linear double-stranded DNA (dsDNA) 
fragment to produce 3’-ended single-stranded 
DNA (ssDNA) overhangs. The  gene 
encodes a pairing protein (Red ) that binds to 
the 3’-ended ssDNA overhangs created by the 
Red  protein and promotes renaturation of 
complementary strands, and is capable of 
mediating strand annealing and exchange 
reaction in vitro (Li and Wilkinson, 1998). The 
recombination function of Red  and Red  
proteins are further assisted by the -encoded 
Gam protein, which inhibits the host RecBCD 
exonuclease V, an intracellular exonuclease 
that degrade the linear pieces of DNA in E. 
coli, in order to linear DNA (PCR products) 
transformable.  
 All obtained mutants were verified by 
PCR colony wich tested for the presence of 
new locus- and junction-specific fragments. 
As shown in Figure 1, The presence of new 
locus (antibiotic resistance gene) was 
appeared by increasing size of band in single 
and double mutants, ΔclpP::Kmr and 
ΔompTclpP::Kmr.  
 The resistance gene was then 
eliminated by using a helper plasmid (pCP20) 
expressing the FLP recombinase, which act on 
the directly repeated FRT (FLP recognition 
target) sites flanking the resistance gene.  FRT 
sites placed in the same chromosome will 
lead to a deletion or inversion of the antibiotic 
resistance segment by FLP recombinase that 
produced by the strain with an easy curable 
FLP-expressing plasmid (pCP20) 
(Cherephanov et al., 1995). After excision of 
the antibiotic-resistance determinant such a 
sequence would be left in the chromosome at 
the site of the initial cassette insertion. 
Elimination of the antibiotic resistance gene 
from these mutants reduce the size of band. 
 In mutant growth condition, as shown 
in Figure 2, E. coli protease-deficient mutants 
were grown slowly than did the wild type. 
The data presented here demonstrate that the 
deletion of protease gene has effects on the 
growth of E. coli. Each of single mutants has 
the same tendency to grow faster than the 
double mutant, but was slower than the wild-
type. In other word, the double mutants were 
the slowest grown, indicating that deletion of 
more than one protease gene has more 
harmful effects on the E. coli growth. 
However, Lon mutant grow slower than 
several some double mutants. It is due to that 
this protease catalyzes an initial rate-limiting 
step in the degradative pathway that is 
necessary for E. coli growth (Goff and 
Goldberg, 1987; Surpuran et al., 2002).  
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 Several double mutants were also 
difficult to survive in a viable condition 
especially on solid growth media. These 
mutants show a variety of other phenotypic 
alteration which seem to be resulted from 
their decreased ability to degrade certain 
short-lived protein (Gottesman, 1996). We 
had attempted to make triple mutants, 
however all of such trials were unsuccessful, 
suggesting that deletion of double or more 
certain protease genes might give harmful 
effects on the growth and viability of E. coli 
cells. This suggestion is based on the role of 
these proteases in the rapid turnover of short-
lived regulatory protein for balanced growth 
of E. coli (Hengge and Bukau, 2003). 
Moreover, as reported previously, deletion of 
the above protease in E. coli leads to mucoidy 
and reduced strain fitness (Goff and 
Goldberg, 1987; Jones et al., 2002; Weichart et 
al., 2002). Jiang et al., (2001) also reported that 
deletion of protease gene in E. coli made the 
cell growth quite poor.  
 
CONCLUSION 
 
 In conclusion, we have constructed 
four single and double protease-deficient 
mutants in E. coli using combination of one-
step chromosomal disruption and P1 phage 
transduction methods. Using the methods, 
desired mutations can be made in any part of 
the DNA, independent of the presence of 
appropriate restriction enzyme sites. The 
combination of these methods allowed us to 
make more than one mutation, suggesting 
that the method is useful to create molecular 
diversity to other bacteria. 
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